Skip to contentE
Enveric Biosciences, Inc.
E
ENVBEnveric Biosciences, Inc. Q3 2016 · 10-Q
Revenue$10.06M$10.06M+125.4% vs Q3 2015 Net Income-$1.72M-$1.72MN/M vs Q3 2015 EPS Diluted-$0.13-$0.13N/M vs Q3 2015 Gross Profit$1,696,598+17.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,831,413N/M Margins · derivedGross margin16.9%−15.4 pt vs Q3 2015
Operating margin-12.8%−5.8 pt vs Q3 2015
Net margin-17.1%−13.5 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end